Piffanelli A - Search Results

1

Quality control of cathepsin-D measurement by the EORTC Receptor Study Group.

Benraad TJ, Geurts-Moespot A, Sala M, Piffanelli A, Ross A, Foekens JA. Benraad TJ, et al. Among authors: piffanelli a. Eur J Cancer. 1992;28(1):72-5. doi: 10.1016/0959-8049(92)90388-i. Eur J Cancer. 1992. PMID: 1567696

2

An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood.

Grebenchtchikov N, Sweep CG, Geurts-Moespot A, Piffanelli A, Foekens JA, Benraad TJ. Grebenchtchikov N, et al. Among authors: piffanelli a. J Immunol Methods. 2002 Oct 15;268(2):219-31. doi: 10.1016/s0022-1759(02)00213-2. J Immunol Methods. 2002. PMID: 12215390

3

EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols.

Span P, Heuvel J, Romain S, Piffanelli A, Martin PM, Geurts-Moespot A, Sweep F. Span P, et al. Among authors: piffanelli a. Anticancer Res. 2000 Mar-Apr;20(2A):681-7. Anticancer Res. 2000. PMID: 10810340

4

Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in Oncologia.

Paradiso A, Mangia A, Correale M, Abbate I, Ferri G, Piffanelli A, Catozzi L, Amadori D, Riccobon A, De Lena M. Paradiso A, et al. Among authors: piffanelli a. Breast Cancer Res Treat. 1992;23(1-2):63-70. doi: 10.1007/BF01831477. Breast Cancer Res Treat. 1992. PMID: 1446053

5

Plasminogen activator system in serum and amniotic fluid of euploid and aneuploid pregnancies.

Vesce F, Scapoli C, Giovannini G, Piffanelli A, Geurts-Moespot A, Sweep FC. Vesce F, et al. Among authors: piffanelli a. Obstet Gynecol. 2001 Mar;97(3):404-8. doi: 10.1016/s0029-7844(00)01144-3. Obstet Gynecol. 2001. PMID: 11239646

6

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group) trial.

Boccardo F, Rubagotti A, Amoroso D, Sismondi P, Genta F, Nenci I, Piffanelli A, Farris A, Castagnetta L, Traina A, et al. Boccardo F, et al. Among authors: piffanelli a. Eur J Cancer. 1992;28(2-3):673-80. doi: 10.1016/s0959-8049(05)80123-6. Eur J Cancer. 1992. PMID: 1591091 Clinical Trial.

7

A new approach to the quality control of steroid receptor assays.

Borsotti M, Quercioli M, D'Ettole R, Piffanelli A, Messeri G. Borsotti M, et al. Among authors: piffanelli a. Clin Chem. 1988 Oct;34(10):2076-9. Clin Chem. 1988. PMID: 3168219

8

Cathepsin D versus other prognostic factors in breast cancer. Results and controversies of a multicenter study on 2575 cases.

Pelizzola D, Gion M, Paradiso A, Dittadi R, Correale M, Mione R, Piffanelli A. Pelizzola D, et al. Among authors: piffanelli a. Int J Biol Markers. 1996 Jul-Sep;11(3):139-47. doi: 10.1177/172460089601100301. Int J Biol Markers. 1996. PMID: 8915708

9

Estrogen and progesterone measurement and its quality control in breast cancer: a reappraisal.

Piffanelli A, Giovannini G, Pelizzola D, De Bortoli M. Piffanelli A, et al. Int J Biol Markers. 1986 Jan-Apr;1(1):15-28. doi: 10.1177/172460088600100104. Int J Biol Markers. 1986. PMID: 3320222

10

Steroid receptor assays: an Italian quality assessment program.

Piffanelli A, Giovannini G, Pelizzola D, De Bortoli M, Catozzi L, Giganti M. Piffanelli A, et al. Ann Ist Super Sanita. 1991;27(3):523-9. Ann Ist Super Sanita. 1991. PMID: 1809075 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters